Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Current understanding of the role of Epstein-Barr virus in lymphomagenesis and therapeutic approaches to EBV-associated lymphomas.

Cohen JI, Bollard CM, Khanna R, Pittaluga S.

Leuk Lymphoma. 2008;49 Suppl 1:27-34. doi: 10.1080/10428190802311417. Review.

2.

EBV-related lymphomas: new approaches to treatment.

Kanakry JA, Ambinder RF.

Curr Treat Options Oncol. 2013 Jun;14(2):224-36. doi: 10.1007/s11864-013-0231-y.

4.

Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas.

Liu Z, Savoldo B, Huls H, Lopez T, Gee A, Wilson J, Brenner MK, Heslop HE, Rooney CM.

Recent Results Cancer Res. 2002;159:123-33.

PMID:
11785836
5.

Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy.

Adhikary D, Behrends U, Boerschmann H, Pfünder A, Burdach S, Moosmann A, Witter K, Bornkamm GW, Mautner J.

PLoS One. 2007 Jul 4;2(7):e583. Review.

6.

Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.

Leong IT, Fernandes BJ, Mock D.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Aug;92(2):184-93.

PMID:
11505266
7.

Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target.

Tse E, Kwong YL.

Exp Mol Med. 2015 Jan 23;47:e136. doi: 10.1038/emm.2014.102. Review.

8.

The biology of Epstein-Barr virus in post-transplant lymphoproliferative disease.

Hsieh WS, Lemas MV, Ambinder RF.

Transpl Infect Dis. 1999 Sep;1(3):204-12. Review.

PMID:
11428990
9.

Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.

Cohen M, De Matteo E, Narbaitz M, Carreño FA, Preciado MV, Chabay PA.

Int J Cancer. 2013 Apr 1;132(7):1572-80. doi: 10.1002/ijc.27845. Epub 2012 Oct 17.

10.

Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy.

Sherritt MA, Bharadwaj M, Burrows JM, Morrison LE, Elliott SL, Davis JE, Kear LM, Slaughter RE, Bell SC, Galbraith AJ, Khanna R, Moss DJ.

Transplantation. 2003 May 15;75(9):1556-60.

PMID:
12792514
11.

Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice.

Whitehurst CB, Li G, Montgomery SA, Montgomery ND, Su L, Pagano JS.

MBio. 2015 Oct 20;6(5):e01574-15. doi: 10.1128/mBio.01574-15.

12.

T-cell therapies for Epstein-Barr virus-associated lymphomas.

El-Bietar J, Bollard C.

Pediatr Hematol Oncol. 2011 Nov;28(8):627-39. doi: 10.3109/08880018.2011.628367. Review.

PMID:
22023461
13.

T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.

Nowakowska J, Stuehler C, Egli A, Battegay M, Rauser G, Bantug GR, Brander C, Hess C, Khanna N.

Cytotherapy. 2015 Sep;17(9):1280-91. doi: 10.1016/j.jcyt.2015.06.003.

PMID:
26276009
14.
15.

Immunotherapy for Epstein-Barr virus-associated cancers in children.

Straathof KC, Bollard CM, Rooney CM, Heslop HE.

Oncologist. 2003;8(1):83-98. Review.

16.

An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model.

Ma SD, Yu X, Mertz JE, Gumperz JE, Reinheim E, Zhou Y, Tang W, Burlingham WJ, Gulley ML, Kenney SC.

J Virol. 2012 Aug;86(15):7976-87. doi: 10.1128/JVI.00770-12. Epub 2012 May 23.

17.

Malignancies associated with epstein-barr virus: pathobiology, clinical features, and evolving treatments.

Neparidze N, Lacy J.

Clin Adv Hematol Oncol. 2014 Jun;12(6):358-71. Review.

PMID:
25003566
18.
19.

Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells.

Ricciardelli I, Blundell MP, Brewin J, Thrasher A, Pule M, Amrolia PJ.

Blood. 2014 Oct 16;124(16):2514-22. doi: 10.1182/blood-2014-01-553362. Epub 2014 Sep 2.

20.

A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation.

Uhlin M, Okas M, Gertow J, Uzunel M, Brismar TB, Mattsson J.

Cancer Immunol Immunother. 2010 Mar;59(3):473-7. doi: 10.1007/s00262-009-0789-1. Epub 2009 Nov 12.

PMID:
19908041

Supplemental Content

Support Center